期刊文献+

17例全肝和9例活体肝移植术后感染病原菌分析 被引量:3

Analysis of infection pathogens after full liver transplantation and living donor liver transplantation
下载PDF
导出
摘要 目的:通过研究全部以及部分肝移植术后感染的病原菌分布等特点,探讨肝移植术后抗感染的有效治疗方式。方法:采用26例肝移植患者术后送检的血液经细菌常规培养、真菌培养所分离出的病原菌进行分析。结果:17例全肝移植术后细菌性感染的发生率为94.1%,病原菌中革兰阴性杆菌占72.4%,9例活体肝移植患者感染发生率88.9%,革兰阳性球菌53.99%。结论:肝移植术后常会出现细菌感染,但活体肝移植患者以革兰阳性球菌感染为主,而全肝移植以革兰阴性杆菌为主,本研究认为,相对而言,活体肝移植患者术后感染较易控制。 Objective:To explore the effective anti--infection therapy by studying main infection pathogens after complete and partial liver transplantation. Methods:The bacterial culture and fungi culture of blood from 26 eases of liver transplantation were performed from which pathogenic bacteria were separated and analyzed. Results:The incidence of bacterial infection after full liver transplantation was 94.1%, and the gram negative bacilli accounted for 72.4 %. The incidence of bacterial infections after living donor liver transplantation was 88. 9 % ,and the gram positive cocci accounted for 53. 99%. Conclusion-The bacteria infection often occurs after liver transplantation. The main pathogenic organisms of infection were gram positive cocci after living donor liver transplantation, and the main pathogenic organisms of infection were gram negative bacilli after full liver transplantation. In contrast, the postoperative infection after living donor liver transplantation is more easily controlled.
出处 《黑龙江医药科学》 2010年第2期23-24,共2页 Heilongjiang Medicine and Pharmacy
关键词 肝移植 感染 细菌 liver transplantation infection bacteria
  • 相关文献

参考文献9

二级参考文献46

  • 1黄华 彭常军.人类苍白杆茵致脑膜炎一例.中华医学检验杂志,1999,22(4):241-241.
  • 2张全华 雷殿刚 魏莲花.从胸水中分离出1株人赭杆茵.临床检验杂志,2000,18(2):89-90.
  • 3[1]Singh N.Infectious diseases in the liver transplant recipient. Semin Gastrointest Dis,1998; 9(3):136
  • 4[2]George DL,Arnow PM,Fox AS.Bacterial infection as a complication of liver transplantation epidemiology and risk factors.Rev Infect Dis,1991,13(3):387
  • 5[3]Singh N, Paterson DL, Chang FY, et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis,2000, 30(2):322
  • 6Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal injections complicating orthotopic liver trans-plantation[J]. JID, 1994, 170(9): 644-652.
  • 7Drew JW, Emmanouilides C, Ronald WB. Infections in liver transplant recipients[J]. Clin Infect Dis, 1995, 21(5): 1077-1091.
  • 8Hadley S, Karchuner AW. Fungal infections in solid organ transplant recipients[J]. Inject Dis Clin North Am, 1995, 9(4): 1045-1074.
  • 9John M, Rabkin MD, Susan L, et al. Association of fungal in-fection and increased mortality in liver transplant recipients[J].Am J Surg, 2000, 179(5): 426-430.
  • 10Winston DJ, Pakrasi A, Busuttil RB. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind,placebo-controlled trial[J]. Ann Intern Med, 1999, 131(10):729-737.

共引文献79

同被引文献27

  • 1刘树人,罗显荣,骆丽敏,曾国兵,余宙耀,李灼亮.肝移植术后早期细菌感染流行病学分析[J].中国现代医学杂志,2008,18(20):2998-3001. 被引量:3
  • 2ZHANG Q, LV Y G,XI S H, et al. Hospital- acquire infection af-ter liver transplantations [ J ].中华医院感染学杂志,2010,20(11):1643-1646.
  • 3CHEN T C, LIN P C, CHI C Y,et al. Infection in liver transplant reeipientsd Analysis of 68 eases at teaching hospital in Taiwan[ J ]. J Microbiol Immuno lnf, 2011,44(4) :303-309.
  • 4SUN N, GU J. Dose-decreasing of immunosuppressant after organtransplantation by serious infection [ J ].中国药学杂志,2010,46(4):304-307.
  • 5Shahcheraghi F,Nikbin VS,Feizabadi MM. Identification and genetic characterization of metallo beta-lactamase-produ-cing strains of Pseudommonas aeruginosa in Tehran,Iran[J].{H}New Microbiologica,2010,(3):243-248.
  • 6Barbolla R, Catalano M, Orman BE, et al. Class 1 integrons in crease trimethoprim sulfamethoxazole MICs against epidemiologi- cally unrelated Stenotrophomonas maltophilia Isolates [J]. An timincrob Agents Chemother, 2004, 48 (2): 666-9.
  • 7AI-Jasser AM. Stenohomonas maltophilia resistant to trime- thoprim-sulfamethoxazole: an increasing problem[J].Ann Clin Microbiol Antimicrob, 2006, 5:23.
  • 8Hu LF, Chang X, Ye Y, et al. Stenotrophomonas maltophilia re- sistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron[J]. Int JAntimierob Agents, 2011, 37(3): 230 4.
  • 9Giamarellos-Bourboulis EJ, Karnesis L. In vitro killing effect of moxifloxaein on clinical isolates of Stenotrophomonas maltophilia resistant to trimethoprim sulfamethoxazole[J]. Antimincrob A gents Chemother, 2002, 46(12): 3997-9.
  • 10Neela V, Rankouhi S Z, Belkum A, et al. Stenotrophomonas maltophilia in Malaysia.. molecular epidemiology and trime- thoprim sulfamethoxazole resistance[J]. Int J Infect Dis, 2012, 16(8), e603-7.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部